IP Library Granted Patent US 7,423,043
Granted Patent B2
US 7,423,043 · App. 11/354,636 · Granted Sep 9, 2008

4-Piperidin-1-yl-7

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,423,043
App. No.
11/354,636
Granted
Sep 9, 2008
Kind
B2
Abstract

Substituted 4-piperidin-1-yl-7H-pyrrolo[2,3-D]pyrimidine compounds are disclosed, as well as compositions comprising them and methods of their use for the treatment, prevention and management of various diseases and disorders.

Claims (40)

1. A compound of the formula:

or a pharmaceutically acceptable salt thereof, wherein:

A 1 and A 2 are each independently optionally substituted aryl or heteroaryl;

X is —CH 2 — or —C(O)—;

Y is —O—, —NR 5 —, —S(O) n NR 5 —, —C(O)NR 5 —, —NR 5 C(O)—, —C(O)—, or —S(O) n —;

n is 1 or 2;

R 1 and R 2 are each independently hydrogen, halo, cyano, hydroxy, —NR 3 R 4 , [thio,] or optionally substituted alkyl, alkoxy, aryl, arylalkyl, heterocycle or heterocycloalkylalkyl; and

R 3 , R 4 , and R 5 are each independently hydrogen or optionally substituted alkyl, aryl, arylalkyl, heterocycle or heterocycloalkylalkyl.

2. The compound of claim 1 , wherein R 2 is hydrogen, cyano, methyl or halo.

3. The compound of claim 1 , wherein R 3 is hydrogen or alkyl.

4. The compound of claim 1 , wherein R 4 is hydrogen or alkyl.

5. The compound of claim 1 , wherein R 5 is hydrogen or lower alkyl.

6. A compound of the formula:

or a pharmaceutically acceptable salt thereof, wherein:

A 1 is optionally substituted aryl or heteroaryl;

X is —CH 2 — or —C(O)—;

Y is —O—, —NR 5 —, —S(O) n NR 5 —, —C(O)NR 5 —, —NR 5 C(O)—, —C(O)—, or —S(O) n —;

n is 1 or 2;

R 1 and R 2 are each independently hydrogen, halo, cyano, hydroxy, —NR 3 R 4 , [thio,] or optionally substituted alkyl, alkoxy, aryl, arylalkyl, heterocycle or heterocycloalkylalkyl;

R 3 , R 4 , and R 5 are each independently hydrogen or optionally substituted alkyl, aryl, arylalkyl, heterocycle or heterocycloalkylalkyl; and

R 6 is hydrogen, halo, cyano, hydroxy, alkoxy, amino or optionally substituted alkyl.

7. The compound of claim 6 , wherein A 1 is thiazolyl or optionally substituted phenyl.

8. The compound of claim 6 , wherein Y is —O—, —C(O)—, —NHC(O)— or —C(O)NH—.

9. The compound of claim 6 , wherein Y is —S(O) n NR 5 — or —S(O) n —, and n is 2.

10. The compound of claim 6 , wherein R 1 is hydrogen.

11. The compound of claim 6 , wherein R 2 is hydrogen, cyano, methyl or halo.

12. A compound of the formula:

or a pharmaceutically acceptable salt thereof, wherein:

A 2 is optionally substituted aryl or heteroaryl;

X is —CH 2 — or —C(O)—;

Y is —O—, —NR 5 —, —S(O) n NR 5 —, —C(O)NR 5 —, —NR 5 C(O)—, —C(O)—, or —S(O) n —;

n is 1 or 2;

R 1 and R 2 are each independently hydrogen, halo, cyano, hydroxy, —NR 3 R 4 , [thio,] or optionally substituted alkyl, alkoxy, aryl, arylalkyl, heterocycle or heterocycloalkylalkyl; and

R 3 , R 4 , and R 5 are each independently hydrogen or optionally substituted alkyl, aryl, arylalkyl, heterocycle or heterocycloalkylalkyl.

13. The compound of claim 12 , wherein A 2 is optionally substituted phenyl, indanyl, indenyl, indolinyl, or pyridyl.

14. The compound of claim 12 , wherein Y is —O—, —C(O)—, —NHC(O)— or —C(O)NH—.

15. The compound of claim 12 , wherein Y is —S(O) n NR 5 — or —S(O) n —, and n is 2.

16. The compound of claim 12 , wherein R 1 is hydrogen.

17. The compound of claim 12 , wherein R 2 is hydrogen, cyano, methyl or halo.

18. A composition comprising a compound of claim 1 and a solvent.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded May 5, 2026
From: OXFORD FINANCE LLC
To: LEXICON PHARMACEUTICALS, INC.; LEXICON PHARMACEUTICALS
Reel/Frame 075545/0601 →
SECURITY INTEREST Recorded May 4, 2026
From: LEXICON PHARMACEUTICALS, INC.; LEXICON PHARMACEUTICALS (NEW JERSEY), INC.; LION ACQUISITION CORPORATION
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 075498/0899 →
SECURITY INTEREST Recorded Mar 17, 2022
From: LEXICON PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 059432/0709 →
CHANGE OF NAME Recorded Feb 24, 2022
From: LEXICON GENETICS INCORPORATED
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 059240/0463 →
RELEASE OF SECURITY INTEREST Recorded Sep 14, 2020
From: BIOPHARMA CREDIT PLC
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 053767/0445 →
SECURITY INTEREST Recorded Dec 20, 2017
From: LEXICON PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 044958/0377 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 6, 2006
From: RAWLINS, DAVID BRENT; VORONKOV, MICHAEL VICTOR; ZHANG, YULIAN
To: LEXICON GENETICS INCORPORATED
Reel/Frame 017634/0210 →